After treatment with differing concentrations of niclosamide, we observed that niclosamide decreased PD-L1 expression as well as STAT3 phosphorylation in a concentration-dependent manner in NSCLC cell lines (Fig. 3b-d, h-i). The gene discussed is CD274; the disease is non-small cell lung carcinoma.